Literature DB >> 34882517

Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method.

Luiza L Bagno1, Alessandro G Salerno1, Wayne Balkan1,2, Joshua M Hare1,2.   

Abstract

INTRODUCTION: Mesenchymal stromal cells (MSCs; AKA mesenchymal stem cells) stimulate healing and reduce inflammation. Promising therapeutic responses are seen in many late-phase clinical trials, but others have not satisfied their primary endpoints, making translation of MSCs into clinical practice difficult. These inconsistencies may be related to the route of MSC delivery, lack of product optimization, or varying background therapies received in clinical trials over time. AREAS COVERED: Here we discuss the different routes of MSC delivery, highlighting the proposed mechanism(s) of therapeutic action as well as potential safety concerns. PubMed search criteria used: MSC plus: local administration; routes of administration; delivery methods; mechanism of action; therapy in different diseases. EXPERT OPINION: Direct injection of MSCs using a controlled local delivery approach appears to have benefits in certain disease states, but further studies are required to make definitive conclusions regarding the superiority of one delivery method over another.

Entities:  

Keywords:  Local Injection; Mechanism of Action; Mesenchymal Stem Cells; Mscs

Mesh:

Year:  2021        PMID: 34882517      PMCID: PMC8934282          DOI: 10.1080/14712598.2022.2016695

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  165 in total

Review 1.  Attenuation of frailty in older adults with mesenchymal stem cells.

Authors:  Victoria Florea; Luiza Bagno; Angela C Rieger; Joshua M Hare
Journal:  Mech Ageing Dev       Date:  2019-06-07       Impact factor: 5.432

2.  Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions.

Authors:  Fatima Zriek; John A Di Battista; Nada Alaaeddine
Journal:  Curr Stem Cell Res Ther       Date:  2021-02-02       Impact factor: 3.828

Review 3.  Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.

Authors:  Guido Moll; James A Ankrum; Julian Kamhieh-Milz; Karen Bieback; Olle Ringdén; Hans-Dieter Volk; Sven Geissler; Petra Reinke
Journal:  Trends Mol Med       Date:  2019-01-30       Impact factor: 11.951

Review 4.  Stem Cell Therapies in Cardiovascular Disease.

Authors:  Maia Terashvili; Zeljko J Bosnjak
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-04-26       Impact factor: 2.628

5.  Experimental and Computational Insight Into Human Mesenchymal Stem Cell Paracrine Signaling and Heterocellular Coupling Effects on Cardiac Contractility and Arrhythmogenicity.

Authors:  Joshua Mayourian; Timothy J Cashman; Delaine K Ceholski; Bryce V Johnson; David Sachs; Deepak A Kaji; Susmita Sahoo; Joshua M Hare; Roger J Hajjar; Eric A Sobie; Kevin D Costa
Journal:  Circ Res       Date:  2017-06-22       Impact factor: 17.367

Review 6.  Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.

Authors:  Samuel Golpanian; Ariel Wolf; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

7.  Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.

Authors:  Lara Lacerda; Bisrat G Debeb; Daniel Smith; Richard Larson; Travis Solley; Wei Xu; Savitri Krishnamurthy; Yun Gong; Lawrence B Levy; Thomas Buchholz; Naoto T Ueno; Ann Klopp; Wendy A Woodward
Journal:  Breast Cancer Res       Date:  2015-03-20       Impact factor: 6.466

Review 8.  Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells.

Authors:  Alix K Berglund; Lisa A Fortier; Douglas F Antczak; Lauren V Schnabel
Journal:  Stem Cell Res Ther       Date:  2017-12-22       Impact factor: 6.832

9.  Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.

Authors:  Dileep R Yavagal; Baowan Lin; Ami P Raval; Philip S Garza; Chuanhui Dong; Weizhao Zhao; Erika B Rangel; Ian McNiece; Tatjana Rundek; Ralph L Sacco; Miguel Perez-Pinzon; Joshua M Hare
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

10.  Treatment of Myocardial Infarction with Gene-modified Mesenchymal Stem Cells in a Small Molecular Hydrogel.

Authors:  Zhiye Wu; Guoqin Chen; Jianwu Zhang; Yongquan Hua; Jinliang Li; Bei Liu; Anqing Huang; Hekai Li; Minsheng Chen; Caiwen Ou
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

View more
  1 in total

1.  Mesenchymal Stem/Stromal Cells as a Therapeutic Tool in Cell-Based Therapy and Regenerative Medicine: An Introduction Expertise to the Topical Collection.

Authors:  Makram Merimi; Hassan Fahmi; Joery De Kock; Charline Beguin; Arsène Burny; Guido Moll; Alessandro Poggi; Mehdi Najar
Journal:  Cells       Date:  2022-10-08       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.